Kinase activity was measured by quantifying the amount of ADP produced from the kinase reaction. The luminescent signal from the assay was correlated with the amount of ADP present and is directly correlated with the amount of kinase activity. Compounds 1-18 and staurosporine were diluted in 10% DMSO and 2.5µl of the dilution was added to a 25µl reaction so that the final concentration of DMSO is 1% in all of reactions. The 25 µl reaction mixture contained 40 mM Tris, pH 7.4, 10 mM MgCl 2 , 0.1 mg/ml BSA, 1 mM DTT, 10 µM ATP, Kinase substrate peptide, 10 µM ATP and the target kinase enzyme. EGFR reactions were conducted at 30 o C for 45 minutes using 0.2 mg/ml Poly (Glu, Tyr) as the EGFR substrate peptide and 5 ng of EGFR kinase. Aurora A reactions were done for 50 min at 30 o C using 0.2 mg/ml Kemptide and 220 ng of Aurora A kinase. After the kinase reaction at 30 o C, 25 µl of ADP-Glo reagent was added and incubated for 45 min at room temperature followed by another 40 min incubation with 50 µl of Kinase detection mixture. All luminescence signals were measured using a BioTek Synergy 2 microplate reader. Kinase activity assays were performed in triplicate at each 2 concentration. The luminescence data were analyzed using the computer software, Graphpad Prism. The difference between luminescence intensities in the absence of Kinase (Lu t ) and in the presence of Kinase (Lu c ) was defined as 100 % activity (Lu t - Background 107 Background 185 
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Binding Affinities for EGFR, AURKA and AURKB
The assay was performed externally at DiscoverX Corporation using a competition binding assay that quantitatively measures the ability of a compound to compete with an immobilized, active-site directed ligand for target kinases AURKA, AURKB and EGFR. 23 The assay is performed by combining three components: DNA-tagged kinase; immobilized ligand; and a test compound. The ability of the test compound to compete with the immobilized ligand was measured via quantitative PCR of the DNA tag. An 11-point 3-fold serial dilution of each test compound was prepared in 100% DMSO at 100x final test concentration and subsequently diluted to 1x in the assay (final DMSO concentration = 1%). Compound Kds were determined using a compound top concentration = 30,000 nM. If the initial Kd determined was < 0.5 nM (the lowest concentration tested), the measurement was repeated with a serial dilution starting at a lower top concentration. Binding constants (Kds) were calculated with a standard doseresponse curve using the Hill equation.
